"Pfizer withdrew Bextra from the market Thursday after U.S. and European regulators said the arthritis drug’s risks may outweigh its benefits.
"The U.S. Food and Drug Administration also asked the company to put a so-called “black box” warning on its painkiller Celebrex, which is a strong cautionary notice on its use.
"Pfizer said it disagrees with the findings, but would comply with both requests as it pursues further discussions with the FDA. The agency previously advised U.S. physicians to limit prescriptions of both drugs due to evidence they might increase the risk of heart problems and stroke." [Red Herring]
